Postoperative Pain Management of Caesarean Section
Launched by MACKAY MEMORIAL HOSPITAL · Aug 12, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different methods of managing pain after a Caesarean section (C-section) can affect recovery. C-sections are common surgeries, but they can cause significant pain afterward, which might lead to complications or even feelings of depression. The goal of this study is to investigate the effectiveness of various pain relief techniques, such as patient-controlled pain management and extended-release medications, to find the best ways to help new mothers feel more comfortable after surgery.
To participate in this study, women aged 20 to 40 who are scheduled for a C-section with spinal anesthesia may be eligible. They should be planning to use specific pain relief methods like intravenous patient-controlled analgesia or a drug called NALDEBAIN. Participants will be involved in a process to help researchers learn which pain management techniques work best, and they will receive appropriate care during their recovery. It's important to note that those with certain medical conditions or histories may not be able to join. If you think you might be interested, talk to your healthcare provider for more information!
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Aged 20 to 40.
- • 2. Planing to undergo caesarean section with spinal anesthesia.
- • 3. Scheduled to undergo cesarean section between 37 and 40 weeks of gestation.
- • 4. American Society of Anesthesiology Physical Class 1-2.
- • 5. Planing to alleviate postoperative pain with intravenous patient-controlled analgesia or administration of NALDEBAIN.
- Exclusion Criteria:
- • 1. Not willing to provide informed consent.
- • 2. Unable to receive opioids or NSAIDs due to contraindication.
- • 3. Long-term use of opioids or drug abuse.
- • 4. Suffering from chronic pain disease.
- • 5. Having medical history of mental illnesses.
- • 6. Diagnosed with Pre-eclampsia or eclampsia.
- • 7. Diagnosed with gestational diabetes.
- • 8. Unsuitable for participation judged by investigator.
About Mackay Memorial Hospital
Mackay Memorial Hospital is a leading healthcare institution dedicated to advancing medical science through innovative clinical research. With a commitment to patient-centered care, the hospital actively sponsors and conducts clinical trials across various therapeutic areas, aiming to develop new treatment options and improve health outcomes. Boasting a team of experienced researchers and healthcare professionals, Mackay Memorial Hospital adheres to rigorous ethical standards and regulatory guidelines, ensuring the safety and well-being of participants while contributing to the global body of medical knowledge. Its collaborative approach fosters partnerships with academic institutions and industry leaders, positioning it as a key player in the advancement of healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Taipei, , Taiwan
New Taipei City, , Taiwan
Patients applied
Trial Officials
Chi-Hsu Wang, M.D.
Principal Investigator
MacKay Memorial Hospital Tamsui Branch
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials